MYLAN Australia has confirmed PBS listing as a Streamlined Authority in the General Schedule for its Tenofovir/Emtricitabine 300/200 pre-exposure prophylaxis (PrEP) against HIV infection for medium to high risk Australians, to become effective from 01 Apr.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Mar 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Mar 18